Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteur principal: Iskandar Idris
Format: Artículo Open Access
Publié: Wiley 2024
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867009891364765696
author Iskandar Idris
author_facet Iskandar Idris
Iskandar Idris
collection Wiley Open Access
contents Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.109 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/doi2.109
format Artículo Open Access
id wiley_oa_10_1002_doi2_109
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
Iskandar Idris
Diabetes, Obesity and Metabolism Now
Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.109 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
topic Diabetes, Obesity and Metabolism Now
url https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.109